Slope of change in HbA(1c) from baseline with empagliflozin compared with sitagliptin or glimepiride in patients with type 2 diabetes

AIMS: To analyse the effect of baseline glycated haemoglobin (HbA(1c)) on the reduction in HbA(1c) with empagliflozin compared with sitagliptin or glimepiride in patients with type 2 diabetes. MATERIALS AND METHODS: Using regression analyses of individual patient data from two Phase III studies, we...

Descripción completa

Detalles Bibliográficos
Autores principales: DeFronzo, Ralph A., Ferrannini, Ele, Schernthaner, Guntram, Hantel, Stefan, Elsasser, Ulrich, Lee, Christopher, Hach, Thomas, Lund, Søren S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354821/
https://www.ncbi.nlm.nih.gov/pubmed/30815552
http://dx.doi.org/10.1002/edm2.16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354821/
https://www.ncbi.nlm.nih.gov/pubmed/30815552
http://dx.doi.org/10.1002/edm2.16

Ejemplares similares